Artificial intelligence in healthcare is no longer in a pilot phase, but is being deployed in a variety of production use cases between diagnostics, drug discovery, clinical operations and patient engagement. According to patient-safety research in the Journal of Patient Safety, about 400,000 patients in the US are harmed from preventable conditions every year, a system issue that was impossible to solve at scale with fragmented, manual patient records, but can be solved with A-driven clinical systems.
This guide will explore real-world applications of AI for healthcare that are clinically and/or operationally validated by the evidence, where generative AI in healthcare fits right now, and data infrastructure decisions that define the success or failure of any healthcare AI initiative in production.
Key Takeaways
- The healthcare AI market is rapidly expanding and is one of the most promising sectors in enterprise technology to witness significant multi-fold growth by the 2030s (Grand View Research, 2024).
- The AI-based reading approach in the MASAI NHS breast cancer screening trial resulted in a 44% reduction in the workload of the radiologists and a 29% improvement in cancer detection rate without increasing the rate of false positives.
- On average, AI can cut drug development expenses by up to 50% (directional estimate based on published molecular modeling studies) in various steps of the drug discovery pipeline.
- Today, the most sophisticated use of generative AI in healthcare is not to diagnose autonomously, but to draft clinical documentation and design molecules at the beginning. Clinician review is a part of every credible scaled deployment.
- Effectiveness of healthcare AI isn't an algorithmic problem, it's a data infrastructure one. Diagnostic tools and documentation relies on clean, connected, governed data.
AI in Healthcare Diagnostics
Benefits: Early detection with greater repeatability across extensive imaging volumes that can be difficult for a fatigued or overloaded clinician to find.
In medical imaging, AI medical performance is most apparent. Patterns associated with disease can be detected by algorithms, before the clinical symptom appears, using large databases of radiology, pathology, and dermatology images. Google DeepMind's model for eye disease diagnosis from retinal scans is one of the highest-evidence benchmarks for AI medical imaging published so far, and matched the accuracy of expert clinicians, according to peer-reviewed research published in the journal Nature Medicine (2018).
The MASAI study is one of the most widely tested studies in the real world conducted in collaboration with the NHS in Sweden. AI-aided mammography reading reduced radiologist workload by 44% and increased cancer detection by 29% while maintaining a status quo in the number of false positives. The significance of the result is that it was compared with the standard double-reading protocol and not a weaker baseline.
Published operational research at Beth Israel Deaconess Medical Center demonstrated that AI-powered microscopy could accurately detect bacteria in a blood sample with 95% accuracy, thus cutting the wait time for patients starting targeted antibiotic treatment.
But it's not a demo in the lab that makes well-designed AI and ML development worthwhile; it's the gap between that clinical research finding and a production-ready tool.
2. AI for Healthcare Drug Discovery
Consequence: Attrition at initial discovery phases, more targeted treatment recommendations.
In the field of drug development, medicine is transforming the economic landscape of the drug industry with the help of medical artificial intelligence. Only about 10% of the drugs that enter the clinical trial phase are actually introduced to the market. A molecular modeling platform powered by artificial intelligence (AI) sifts through compounds and predicts bio-target interactions in advance, thereby uncovering potential compound rejection in an early and cost-effective manner before a company invests large resources. Research studies have shown that the adoption of AI can cut down development expenses by up to 50%, with the precise savings varying based on the specific point in the pipeline where technology is implemented. This is a forward-looking assessment based on existing studies, which is not a prediction.
Precision medicine on the treatment side seeks to identify the genetic and clinical characteristics of each patient, and determine the likelihood of their response to a particular immunotherapy or drug, rather than relying on the average clinical response of the general population to the same treatment. Another example of AI-led precision in surgical planning and execution is through the use of robotic surgery platforms that have helped in more than 10 million procedures, with effectiveness of the procedures ranging from 94% to 100% depending on their type.
3. AI in Patient Engagement
Result: Better management of treatment adherence and earlier detection of changes between treatment visits.
When a patient gets abnormal heart rhythms, excessive sleep disturbances or unusual movement differences all of which could be signs of a potential problem AI-driven monitoring systems and wearable devices can alert clinicians, even if these symptoms aren't noticed on the next visit. The personalized notifications bring clinical care home, where most chronic-condition management takes place.
Intelligent symptom checkers are a fundamental part of telehealth platforms that help patients receive appropriate care before they arrive in an emergency department, and those who do make it to an ED receive a lower level of care since non-emergent jobs were handled through telehealth.
4. AI in Healthcare Operations
Impact: Smoother workflow for clinical staff and quicker operational decisions.
Natural language processing (NLP) for clinical documentation is one of the most rapidly applications of generative AI in healthcare. Documentation is always cited as one of the biggest causes of burnout by clinicians. An AI-based bed assignment system at Johns Hopkins led to a near real-time match of bed availability with patient acuity and staffing, not to clinical diagnosis, and helped cut the time it took to assign beds in the ED by 38%.
Another less talked-about yet crucial use of AI is the ability to detect abnormalities in billing and claims patterns across massive insurance datasets, which is a far more efficient process for teams of AI than manual review teams doing the same at the same speed.
Generative AI In Healthcare: Capabilities and Limitations
The two main use cases for generative AI in healthcare sector are related to clinical documentation and molecule design at the front end of the process. Diagnostic AI is neither. An autonomous diagnostic model is not the same as current deployments that are scaling, and they are a lower risk model, where clinician review is designed into the workflow.
The arrival of AI in medicine is a game-changer, according to Dr. Eric Topol, a cardiologist and author of Deep Medicine, but the testing results in a lab should not be the standard by which one judges how quickly AI can enter into clinical practice with less oversight. The most defensible implementations take a step-by-step approach: first use AI in workflows where the clinician reviews all outputs, then in workflows where clinical review is not built in.
Embedded Analytics for a Digital Health Startup: Real World Example
Outcome: Healthcare organization that can gain actionable clinical and financial insights from previously siloed patient data.
A digital health startup in the Bay Area was looking for a platform to integrate patient visit data from various fragmented sources and convert it into insights for operational efficiency for healthcare professionals such as clinicians and administrators, a problem that's common across most healthcare AI: siloed EHR data, multiple source systems, no unified view.
Chirpn created and implemented an embedded analytics platform with Yellowfin Server on Google Cloud that integrates seamlessly with the client's Epic EHR platform. Within 45–60 days, the team has scoped, built and deployed more than 50 clinical operations monitoring and patient wait-time analysis reports using Chirpn's AutoPATH AI orchestrated delivery framework. The operational need to obtain patient history reliably in near real-time was crucial during COVID-19, and the platform provided the data visibility required to ensure continuity of clinical care. As the organization grew, so did the architecture.
Why Chirpn for Healthcare AI
Effectiveness of healthcare AI is a data infrastructure challenge rather than an algorithm challenge. Chirpn's approach to AI for healthcare begins with the data; EHR integration, system connectivity, and well-controlled data pipelines are the actual food for all diagnostic tools and documentation models. The Bay Area engagement above is just one of 100+ AI projects completed in various industries, in a framework of AutoPATH – from scoping to production in 45-60 days.
With its expertise in the field, Chirpn's team can scope the right architecture from the get-go if your organization is looking to launch a healthcare AI initiative, whether it's a data platform, a clinical analytics build, or an AI-supported workflow.
Frequently Asked Questions.
What is artificial intelligence in healthcare?
Artificial intelligence in healthcare encompasses the use of machine learning algorithms, natural language processing (NLP), and predictive analytics for clinical and operational challenges, such as interpreting medical images for diagnosis, predicting drug side effects, streamlining clinical documentation workflows, and optimizing hospital operations. It is not meant to replace clinicians, but to complement them in their capacity and consistency, especially at scale.
What are the major applications of AI in healthcare?
The four main use cases of health care AI are: (1) diagnostics reading medical images and finding patterns of disease risk; (2) drug discovery and precision medicine; (3) patient engagement wearables and telehealth triage tools; and (4) clinical operations documentation, fraud detection and scheduling. Both have transitioned from pilots to deployment in a large number of health systems.
Is AI medical diagnosis accurate or not?
Results are context-specific. The AI-backed reading increased the number of cancer cases identified by 29%, but did not raise the false-positive rate, while reducing the number of radiologist reads by 44%, according to the results of the MASAI NHS breast-cancer screening trial. This is a result that is supported by evidence in one particular context. AI is not replacing clinicians in all clinical contexts and existing production deployments require clinician review.
Why is generative AI being used in healthcare today?
Some of the scaled-up applications of generative AI in healthcare today include clinical documentation, where medical interactions with patients are captured and summarized for physician review, and initial drug-candidate design. There are no known and viable systems in use that use autonomous AI diagnosis in production at scale. Every scaled use case in which output has an impact on patient care is reviewed by a clinician.
Where is the future of AI in Healthcare?
The future of AI in healthcare is expected to significantly expand the use of Natural Language Processing (NLP) in documentation systems, by leveraging genetic information in precision medicine platforms to determine appropriate treatment, and through the use of predictive analytics in population health management. In the longer term, AI is likely to be able to expand its diagnostic autonomy as well in certain well-validated imaging settings – but regulatory frameworks (FDA SaMD guidance) will guide that development.
What are the biggest challenges to AI adoption in healthcare?
Common challenges consist of: HIPAA compliance and other data privacy regulations; clinical validation before diagnostic or treatment tools can be utilized; interoperability with older EHR and PACS systems; clinician trust in AI-driven recommendations; and regulatory oversight under FDA software-as-a-medical-device (SaMD) guidance for tools that impact the diagnosis or treatment process.
